Syneron Announces New Ground Breaking evolastin™ Procedure

Syneron Announces New Ground Breaking evolastin™ Procedure

Syneron announces the launch of evolastin™ – the industry’s first energy-based dermal
remodeling procedure that delivers controlled radio frequency energy directly to the deep
dermis to stimulate the skin’s natural production of collagen, elastin and hyaluronic acid
in a single treatment.

Read More HERE

 

 

 

 

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron®'s signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron® products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.